Clinical characteristics of the 3 subtypes of follicular lymphoma, grade 3
. | FL3a (%) . | FL3b (%) . | FLC (%) . | P . |
---|---|---|---|---|
Total number | 107 (56) | 53 (28) | 30 (16) | |
Sex | ||||
Male | 43 (40) | 30 (57) | 15 (50) | .14 |
Female | 64 (60) | 23 (43) | 15 (50) | |
Age, y | ||||
Median | 61 | 60 | 66 | .33 |
Range | 22-87 | 16-84 | 37-83 | |
Stage | ||||
I/II | 31 (32) | 19 (37) | 12 (43) | .52 |
III/IV | 67 (68) | 33 (63) | 16 (57) | |
B symptoms | ||||
No | 79 (79) | 37 (71) | 22 (79) | .57 |
Yes | 21 (21) | 15 (29) | 6 (21) | |
Extranodal sites | ||||
Fewer than 2 | 90 (90) | 50 (96) | 26 (93) | .43 |
2 or more | 10 (10) | 2 (4) | 2 (7) | |
Karnofsky score | ||||
Higher than 70 | 87 (88) | 47 (92) | 27 (100) | .14 |
70 or lower | 12 (12) | 4 (8) | 0 (0) | |
LDH | ||||
Normal | 72 (77) | 31 (65) | 17 (63) | .16 |
High | 21 (23) | 17 (35) | 10 (37) | |
IPI risk group | ||||
Low (0-2) | 68 (78) | 40 (85) | 19 (76) | .57 |
High (3-5) | 19 (22) | 7 (15) | 6 (24) |
. | FL3a (%) . | FL3b (%) . | FLC (%) . | P . |
---|---|---|---|---|
Total number | 107 (56) | 53 (28) | 30 (16) | |
Sex | ||||
Male | 43 (40) | 30 (57) | 15 (50) | .14 |
Female | 64 (60) | 23 (43) | 15 (50) | |
Age, y | ||||
Median | 61 | 60 | 66 | .33 |
Range | 22-87 | 16-84 | 37-83 | |
Stage | ||||
I/II | 31 (32) | 19 (37) | 12 (43) | .52 |
III/IV | 67 (68) | 33 (63) | 16 (57) | |
B symptoms | ||||
No | 79 (79) | 37 (71) | 22 (79) | .57 |
Yes | 21 (21) | 15 (29) | 6 (21) | |
Extranodal sites | ||||
Fewer than 2 | 90 (90) | 50 (96) | 26 (93) | .43 |
2 or more | 10 (10) | 2 (4) | 2 (7) | |
Karnofsky score | ||||
Higher than 70 | 87 (88) | 47 (92) | 27 (100) | .14 |
70 or lower | 12 (12) | 4 (8) | 0 (0) | |
LDH | ||||
Normal | 72 (77) | 31 (65) | 17 (63) | .16 |
High | 21 (23) | 17 (35) | 10 (37) | |
IPI risk group | ||||
Low (0-2) | 68 (78) | 40 (85) | 19 (76) | .57 |
High (3-5) | 19 (22) | 7 (15) | 6 (24) |
LDH indicates lactate dehydrogenase.